<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731859</url>
  </required_header>
  <id_info>
    <org_study_id>EBRD 001</org_study_id>
    <nct_id>NCT02731859</nct_id>
  </id_info>
  <brief_title>EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve</brief_title>
  <acronym>EBRD</acronym>
  <official_title>EndoBarrier Register Deutschland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GI Dynamics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study ist to determine long-term safety and efficacy in weight reduction
      and improvement of diabetes mellitus of the temporary, endoscopic duodenal-jejunal
      bypass-sleeve EndoBarrier® in a national registry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long-term data are collected by approximately 30 German centers. An electronic
      Case-Report-Form (eCRF) was designed to collect relevant pre-specified items by the Clinical
      Trial Center North (CTC). All German sites that have implanted EndoBarrier® since 2010 were
      invited to provide patient results. Data-acquisition is projected to a period of 5 years and
      a maximum of 1000 patients. An extension of data-acquisition is planned.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Reduction of HbA1C</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of Antidiabetic Medication</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Excess weight loss</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction of BMI</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight reduction</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with treatment-related adverse events</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
    <description>Adverse events associated to implantation, explantation or insertion of EndoBarrier such as bleeding, liver abscess, abdominal pain, nausea, vomiting, duodenal ulcers, duodenal perforation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of subjective Arthropathia</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
    <description>Qualitative Measurement of improvement of subjective Arthropathia, no scale is used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking Status</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of implantation and explantation</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of fasting glucose</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of fasting insulin</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of fasting C-Peptide</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of systolic blood pressure</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of diastolic blood pressure</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of antihypertensive medication</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of total cholesterol</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of LDL-cholesterol</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase of HDL-cholesterol</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of fasting triglycerides</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of antihyperlipidemic medication</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of 25OHD3</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Calcium</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Ferritin</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
    <description>Ferritin will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Hemoglobin</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Vitamin B12</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Albumin</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Folic acid</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Vitamin B1</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Vitamin B6</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of CK</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of AST</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of ALT</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of hsCRP</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of implantation process of the EndoBarrier in minutes</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of ithe explantation process of the EndoBarrier in minutes</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of waist circumference</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of daily caloric intake</measure>
    <time_frame>From Implantation to at least 2 years follow up</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>EndoBarrier</arm_group_label>
    <description>All patients with EndoBarrier treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insertion of EndoBarrier for approximately one year</intervention_name>
    <description>Insertion of EndoBarrier for approximately one year then explantation and follow-up</description>
    <arm_group_label>EndoBarrier</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with either Obesity and/or Diabetes mellitus who are treated with the EndoBarrier
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical decision for treatment with EndoBarrier

          -  informed consent for registry participation

        Exclusion Criteria:

          -  Patients not meeting the inclusion criteria

          -  age &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Aberle</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital Hamburg, Endokrinology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Hinz</last_name>
    <phone>040/741020901</phone>
    <email>ni.sauer@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nina Sauer</last_name>
    <phone>01781642802</phone>
    <email>ninasauer@ymail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heinle</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Donau-Ries Klinik Donauwörth</name>
      <address>
        <city>Donauwörth</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eberl</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Martinus Krankenhaus Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40215</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gijbels</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Forchheim</name>
      <address>
        <city>Forchheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dewald</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg- Abt. Innere Medizin II</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dr. Laubner/Prof. Seufert</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marienhospital Gelsenkirchen</name>
      <address>
        <city>Gelsenkirchen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dederichs</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raddatz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Köln-Weyertal</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Loeff</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Emmaus-Niesky</name>
      <address>
        <city>Niesky</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stengel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elisabeth Klinikum Schmalkalde</name>
      <address>
        <city>Schmalkalden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Petrus Krankenhaus Wuppertal</name>
      <address>
        <city>Wuppertal</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Göbel</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2016</study_first_submitted>
  <study_first_submitted_qc>April 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2016</study_first_posted>
  <last_update_submitted>June 22, 2017</last_update_submitted>
  <last_update_submitted_qc>June 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

